Quantification of capsular polysaccharide of Streptococcus pneumoniae serotype 14 in culture broth samples

Analytical Biochemistry

Volumn 421, Issue 1, 2012, Pages 250-255

  Gogola, Verônica M R ^a   Carmo, Talita S ^a   Geraldo, Carolina S F ^a   Figueiredo, Douglas B ^a   Gonalves, Viviane M ^a  

^a INSTITUTO BUTANTAN   (Brazil)

Author keywords

ELISA; Pneumococcus; Polysaccharide; Quantification

Indexed keywords

BIOCHEMISTRY; CHEMISTRY; POLYSACCHARIDES;

CAPSULAR POLYSACCHARIDES; COEFFICIENT OF VARIATION; COMPETITIVE ELISA; ELISA; PNEUMOCOCCUS; QUANTIFICATION; QUANTIFICATION LIMIT; STREPTOCOCCUS PNEUMONIAE;

STRAIN;

BACTERIAL POLYSACCHARIDE; SULFURIC ACID;

ANALYSIS OF VARIANCE; ARTICLE; BACTERIAL STRAIN; BACTERIUM CULTURE; BROTH DILUTION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; LIMIT OF QUANTITATION; NONHUMAN; PRIORITY JOURNAL; REPRODUCIBILITY; SENSITIVITY ANALYSIS; SEROTYPE; STREPTOCOCCUS PNEUMONIAE;

STREPTOCOCCUS PNEUMONIAE;

EID: 84855894086     PISSN: 00032697     EISSN: 10960309     Source Type: Journal    
DOI: 10.1016/j.ab.2011.11.029     Document Type: Article

References (28)

1. World Health Organization (WHO) Pneumococcal conjugate vaccine for childhood immunization - WHO position paper Wkly. Epidemiol. Rec. 82 2007 93 104
2. R. Austrian Some observations on the pneumococcus and on the current status of pneumococcal disease and its prevention Rev. Infect. Dis. 3 1981 S1 S17
3. C. Muñoz-Almagro, L. Selva, and R. Pallares Influence of pneumococcal vaccine on the incidence of empyema Curr. Opin. Pulm. Med. 16 2010 394 398
4. Organización Panamericana de la Salud, Informe Regional de Sireva II, 2009: datos por país y por grupos de edad sobre las características de los aislamientos de Streptococcus pneumoniae, Haemophilus influenzae y Neisseria meningitidis en procesos invasores, OPS, Washington, 2010.
5. F. Ansaldi, D. De Florentiis, P. Canepa, P. Durando, M. Bassetti, and G. Icardi Serotype replacement in Streptococcus pneumoniae after conjugate vaccine introduction: impact, doubts and perspective for new vaccines Rev. Med. Microbiol. 21 2010 56 64
6. F.C. Csordas, C.T. Perciani, M. Darrieux, V.M. Gonalves, J. Cabrera-Crespo, M. Takagi, M.E. Sbrogio-Almeida, L.C. Leite, and M.M. Tanizaki Protection induced by pneumococcal surface protein A (PspA) is enhanced by conjugation to a Streptococcus pneumoniae capsular polysaccharide Vaccine 26 2008 2925 2929
7. R. Santamaria, C. Goulart, C.T. Perciani, G.C. Barazzone, R. Carvalho Jr., V.M. Gonalves, L.C.C. Leite, and M.M. Tanizaki Humoral immune response of a pneumococcal conjugate vaccine: capsular polysaccharide serotype 14-lysine modified PspA Vaccine 29 2011 8689 8695
8. R. Carvalho Jr., J. Cabrera-Crespo, M.M. Tanizaki, V.M. Gonalves, Development of production and purification processes of recombinant fragment of pneumococcal surface protein A in E. coli using different carbon sources and chromatography sequences. Appl. Microbiol. Biotechnol. (2011), doi:10.1007/s00253-011-3649-9.
9. M.A.B. Kolkman, W. Wakarchuk, P.J.M. Nujiten, and B.A.M. Van Der Zejist Capsular polysaccharide synthesis in Streptococcus pneumoniae serotype 14: molecular analysis of the complete cps locus and identification of genes encoding glycosyltransferases required for the biosynthesis of the tetrasaccharide subunit Mol. Microbiol. 26 1997 197 208 (Pubitemid 27438249)
10. B. Lindberg, J. Lönngren, and D.A. Powell Structural studies on the specific type-14 pneumococcal polysaccharide Carbohydr. Res. 58 1977 177 186
11. S.A. Harding, W.M. Scheld, M.D. Mcgowan, and M.A. Sande Enzyme-linked immunosorbent assay for detection of Streptococcus pneumoniae antigen J. Clin. Microbiol. 10 1979 339 342 (Pubitemid 10233221)
12. S.C. Szu, and L.S. Oravec Detection of "neutral" type 7f and type 14 pneumococcal capsular polysaccharides by immunoelectrophoresis J. Clin. Microbiol. 15 1982 1172 1175 (Pubitemid 12070877)
13. H. Massaldi, M.I. Bessio, N. Suárez, E. Texeira, S. Rossi, and F. Ferreira Features of bacterial growth and polysaccharide production of Streptococcus pneumoniae serotype 14 Biotechnol. Appl. Biochem. 55 2010 37 43
14. WHO Recommendations for the production and control of pneumococcal conjugate vaccines WHO Tech. Rep. Ser. 927 2005 64 98
15. J.S. Kim, E.R. Laskowich, R.G. Arumugham, R.E. Kaiser, and G.J. MacMichael Determination of saccharide content in pneumococcal polysaccharides and conjugate vaccines by GC-MSD Anal. Biochem. 347 2005 262 274 (Pubitemid 41681814)
16. Q. Xua, C. Abeygunawardana, A.S. Ng, A.W. Sturgess, B.J. Harmon, and J.P. Hennessey Jr. Characterization and quantification of C-polysaccharide in Streptococcus pneumoniae capsular polysaccharide preparations Anal. Biochem. 336 2005 262 272 (Pubitemid 40038024)
17. C. Abeygunawardana, T.C. Williams, J.S. Sumner, and J.P. Hennessey Jr. Development and validation of an NMR-based identity assay for bacterial polysaccharides Anal. Biochem. 279 2000 226 240 (Pubitemid 30165011)
18. G. Cuesta, N. Suárez, M.I. Bessio, F. Ferreira, and H. Massaldi Quantitative determination of pneumococcal capsular polysaccharide serotype 14 using a modification of phenol-sulfuric acid method J. Microbiol. Methods 52 2003 69 73 (Pubitemid 35232757)
19. L.C. Paoletti, R.A. Ross, and K.D. Johnson Cell growth rate regulates expression of group B Streptococcus type III capsular polysaccharide Infect. Immun. 64 1996 1220 1226 (Pubitemid 26102382)
20. V.M. Gonalves, T.C. Zangirolami, R.L.C. Giordano, I. Raw, M.M. Tanizaki, and R.C. Giordano Optimization of medium and cultivation conditions for capsular polysaccharide production by Streptococcus pneumoniae serotype 23F Appl. Microbiol. Biotechnol. 59 2002 713 717
21. B. Bednar, and J.P. Hennessey Jr. Molecular size analysis of capsular polysaccharide preparations from Streptococcus pneumoniae Carbohydr. Res. 243 1993 115 130 (Pubitemid 23131029)
22. G.C. Howard, and M.R. Kaser Making and Using Antibodies: A Practical Handbook 2006 CRC Press FL
23. A. Schaffner, C. Michel-Harder, and S. Yeginsoy Detection of capsular polysaccharide in serum for the diagnosis of pneumococcal pneumonia: clinical and experimental evaluation J. Infect. Dis. 163 1991 1094 1102
24. Y. Cruz-Leal, T. Menéndez, E. Coizeau, R.R. Espinosa, L. Canaan, F. Blanco, T. Carmenate, J. Chang, D. Quiñones, I. Tamargo, J. Cremata, V. Verez-Bencomo, and G. Guillén Enzyme-linked immunosorbent assay for quantitative determination of capsular polysaccharide production in Streptococcus pneumoniae clinical isolates Biotechnol. Appl. Biochem. 44 2006 101 108 (Pubitemid 43723341)
25. B. DeSilva, W. Smith, R. Weiner, M. Kelley, J. Smolec, B. Lee, M. Khan, R. Tacey, H. Hill, and A. Celniker Recommendations for the bioanalytical method validation of ligand-binding assays to support pharmacokinetic assessments of macromolecules Pharm. Res. 10 2003 1885 1900 (Pubitemid 37449466)
26. C.M. Macleod, and M.R. Krauss Relation of virulence of pneumococcal strains for mice to the quantity of capsular polysaccharide formed in vitro J. Exp. Med. 92 1950 1 9
27. A. Tomasz Surface components of Streptococcus pneumoniae Rev. Infect. Dis. 3 1981 190 211
28. E. Alonsode Velasco, A.F.M. Verheul, J. Verhoef, and H. Snippe Streptococcus pneumoniae: virulence factors, pathogenesis, and vaccines Microbiol. Rev. 59 1995 591 603